The latest closing stock price for Taysha Gene Therapies as of September 20, 2024 is 2.15.
An investor who bought $1,000 worth of Taysha Gene Therapies stock at the IPO in 2020 would have $-911 today, roughly -1 times their original investment - a -45.33% compound annual growth rate over 4 years.
The all-time high Taysha Gene Therapies stock closing price was 31.75 on January 20, 2021.
The Taysha Gene Therapies 52-week high stock price is 4.32, which is 100.9% above the current share price.
The Taysha Gene Therapies 52-week low stock price is 1.27, which is 40.9% below the current share price.
The average Taysha Gene Therapies stock price for the last 52 weeks is 2.32.
An investor who bought $1,000 worth of Taysha Gene Therapies stock at the IPO in 2020 would have $-911 today, roughly -1 times their original investment - a -45.33% compound annual growth rate over 4 years.
The all-time high Taysha Gene Therapies stock closing price was 31.75 on January 20, 2021.
The Taysha Gene Therapies 52-week high stock price is 4.32, which is 100.9% above the current share price.
The Taysha Gene Therapies 52-week low stock price is 1.27, which is 40.9% below the current share price.
The average Taysha Gene Therapies stock price for the last 52 weeks is 2.32.